Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of Retronectin-Mediated T-Cell Activation on Expansion and Phenotype of CD19-Specific Chimeric Antigen Receptor T Cells
Sophia Stock, Jean‐Marc Hoffmann, Maria‐Luisa Schubert, et al.
Human Gene Therapy (2018) Vol. 29, Iss. 10, pp. 1167-1182
Closed Access | Times Cited: 22

Showing 22 citing articles:

Bioinstructive implantable scaffolds for rapid in vivo manufacture and release of CAR-T cells
Pritha Agarwalla, Edikan A. Ogunnaike, Sarah Ahn, et al.
Nature Biotechnology (2022) Vol. 40, Iss. 8, pp. 1250-1258
Open Access | Times Cited: 126
CAR-T Cell Performance: How to Improve Their Persistence?
Gina López-Cantillo, Claudia Urueña, Bernardo Camacho, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 115
Optimizing Manufacturing Protocols of Chimeric Antigen Receptor T Cells for Improved Anticancer Immunotherapy
Sophia Stock, Michael Schmitt, Leopold Sellner
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6223-6223
Open Access | Times Cited: 123
CAIX-specific CAR-T Cells and Sunitinib Show Synergistic Effects Against Metastatic Renal Cancer Models
Huizhong Li, Jiage Ding, Mengmeng Lü, et al.
Journal of Immunotherapy (2019) Vol. 43, Iss. 1, pp. 16-28
Closed Access | Times Cited: 77
Idelalisib for optimized CD19‐specific chimeric antigen receptor T cells in chronic lymphocytic leukemia patients
Sophia Stock, Rudolf Übelhart, Maria‐Luisa Schubert, et al.
International Journal of Cancer (2019) Vol. 145, Iss. 5, pp. 1312-1324
Open Access | Times Cited: 67
Ibrutinib for improved chimeric antigen receptor T‐cell production for chronic lymphocytic leukemia patients
Fuli Fan, Keun-Young Yoo, Sophia Stock, et al.
International Journal of Cancer (2020) Vol. 148, Iss. 2, pp. 419-428
Open Access | Times Cited: 57
Comparison of IL-2 vs IL-7/IL-15 for the generation of NY-ESO-1-specific T cells
Wenjie Gong, Jean‐Marc Hoffmann, Sophia Stock, et al.
Cancer Immunology Immunotherapy (2019) Vol. 68, Iss. 7, pp. 1195-1209
Closed Access | Times Cited: 42
Akt inhibition at the initial stage of CAR-T preparation enhances the CAR-positive expression rate, memory phenotype and in vivo efficacy.
Qing Zhang, Jiage Ding, Shishuo Sun, et al.
PubMed (2019) Vol. 9, Iss. 11, pp. 2379-2396
Closed Access | Times Cited: 42
Generation of highly proliferative, rejuvenated cytotoxic T cell clones through pluripotency reprogramming for adoptive immunotherapy
Yohei Kawai, Ai Kawana‐Tachikawa, Shuichi Kitayama, et al.
Molecular Therapy (2021) Vol. 29, Iss. 10, pp. 3027-3041
Open Access | Times Cited: 27
c-Met specific CAR-T cells as a targeted therapy for non-small cell lung cancer cell A549
Jingting Min, Chirong Long, Lu Zhang, et al.
Bioengineered (2022) Vol. 13, Iss. 4, pp. 9232-9248
Open Access | Times Cited: 22
Effects of polybrene and retronectin as transduction enhancers on the development and phenotypic characteristics of VHH-based CD19-redirected CAR T cells: a comparative investigation
Fatemeh Nasiri, Samad Muhammadnejad, Fatemeh Rahbarizadeh
Clinical and Experimental Medicine (2022) Vol. 23, Iss. 6, pp. 2535-2549
Closed Access | Times Cited: 10
Tumor-Specific Reactive Oxygen Species Accelerators Improve Chimeric Antigen Receptor T Cell Therapy in B Cell Malignancies
Keun-Young Yoo, Yibin Liu, Lei Wang, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 10, pp. 2469-2469
Open Access | Times Cited: 16
Dual Effects of Cyclooxygenase Inhibitors in Combination With CD19.CAR-T Cell Immunotherapy
Mingya Yang, Lei Wang, Ming Ni, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 14
Cytolytic Activity of CAR T Cells and Maintenance of Their CD4+ Subset Is Critical for Optimal Antitumor Activity in Preclinical Solid Tumor Models
Marianna Mezősi-Csaplár, János Szöllősi, Stephen Gottschalk, et al.
Cancers (2021) Vol. 13, Iss. 17, pp. 4301-4301
Open Access | Times Cited: 12
Engineering Solutions for Mitigation of Chimeric Antigen Receptor T-Cell Dysfunction
Artemis Gavriil, Marta Barisa, Emma Halliwell, et al.
Cancers (2020) Vol. 12, Iss. 8, pp. 2326-2326
Open Access | Times Cited: 12
Influencing factors and solution strategies of chimeric antigen receptor T-cell therapy (CAR–T) cell immunotherapy
Zhengyi Wang, LIANG ZHOU, XIAOYING WU
Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics (2024) Vol. 32, Iss. 9, pp. 1479-1516
Open Access | Times Cited: 1
B‐cell maturation antigen‐specific chimeric antigen receptor T cells for multiple myeloma: Clinical experience and future perspectives
Leopold Sellner, Fuli Fan, Nicola Giesen, et al.
International Journal of Cancer (2020) Vol. 147, Iss. 8, pp. 2029-2041
Open Access | Times Cited: 11
Peripheral leukemia burden at time of apheresis negatively affects the clinical efficacy of CART19 in refractory or relapsed B-ALL
Biping Deng, Jing Pan, Zhaoli Liu, et al.
Molecular Therapy — Methods & Clinical Development (2021) Vol. 23, pp. 633-643
Open Access | Times Cited: 7
In vivo experimental mouse model to test CD19CAR T cells generated with different methods
Anne Fåne, Marit Renée Myhre, Else Marit Inderberg, et al.
Methods in cell biology (2022), pp. 149-161
Closed Access | Times Cited: 3
The role of cellular persistence in CAR T cell therapy
Vivien D. Menkhoff, Sophie Bernhard, Stefanos Michaelides, et al.
Elsevier eBooks (2024)
Closed Access
A living drug: application of CAR-T therapy for lymphoid malignancies and beyond
Anna Strzelec, Anna Klima, Natalia Gawlik-Rzemieniewska, et al.
Acta Haematologica Polonica (2022) Vol. 53, Iss. 4, pp. 241-248
Open Access | Times Cited: 2
Evaluation of Production Protocols for the Generation of NY-ESO-1-Specific T Cells
Wenjie Gong, Lei Wang, Sophia Stock, et al.
Cells (2021) Vol. 10, Iss. 1, pp. 152-152
Open Access | Times Cited: 2
Page 1

Scroll to top